Apr 12, 2019
The Food and Drug Administration (FDA) Determines that Women Taking Addyi May Safely Consume Alcohol
Apr 09, 2019
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Aveo Pharmaceuticals, Inc. of Class Action Lawsuit and Upcoming Deadline -AVEO
Apr 09, 2019
Medunik USA expands access to Siklos® for pediatric sickle cell anemia patients by offering 340B pricing to covered entities through Apexus
Mar 05, 2019
Myovant Sciences to Present at Upcoming Investor Conferences
Feb 06, 2019
Eiger BioPharmaceuticals Announces Patent Protection for Lonafarnib Boosted with Ritonavir for Treatment of Hepatitis Delta Virus Infection in Europe and Japan
Feb 05, 2019
Bayer to Showcase New Data from its Growing Cancer Portfolio at 2019 ASCO GU Cancers Symposium
Nov 15, 2018
Myovant Sciences to Participate in Two Upcoming Investor Conferences
Oct 09, 2018
Eisai to Present LENVIMA® (lenvatinib) and HALAVEN® (eribulin) Data in a Variety of Advanced Cancers at ESMO 2018 Congress
Oct 09, 2018
Bayer to Showcase Latest Oncology Research at ESMO 2018 Congress
Oct 08, 2018
Hepatocellular Carcinoma- Rich Clinical Pipeline can Lead to an Increasing Market Size of USD 3.8 Billion by 2027 for G8 Countries
Sep 13, 2018
AbbVie Presents Upadacitinib Longer-Term (32-Week) and Patient-Reported Outcomes Data from Phase 2b Atopic Dermatitis Study at 27th European Academy of Dermatology and Venereology (EADV) Congress
Aug 29, 2018
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in ACADIA Pharmaceuticals Inc. of Class Action Lawsuit and Upcoming Deadline - ACAD
Aug 16, 2018
Eisai And Merck Announce FDA Approval Of LENVIMA® (lenvatinib) Capsules For First-line Treatment Of Unresectable Hepatocellular Carcinoma (HCC)
Jun 22, 2018
Global Allantoin Market Outlook 2017-2026, With an Expected CAGR of Over 8% - ResearchAndMarkets.com
Jun 21, 2018
Blueprint Medicines Initiates VOYAGER Phase 3 Clinical Trial of Avapritinib in Patients with Advanced Gastrointestinal Stromal Tumors
May 24, 2018
Eisai And Merck Provide Update on Supplemental New Drug Application (sNDA) for Lenvatinib in First-Line Unresectable Hepatocellular Carcinoma
May 17, 2018
Eisai Announces Data at ASCO 2018 Annual Meeting Showcasing LENVIMA® (lenvatinib) and KEYTRUDA® (pembrolizumab) Combination Therapy Under Strategic Oncology Collaboration with Merck
Apr 25, 2018
AbbVie's Upadacitinib Meets Primary and Key Efficacy Endpoints in Phase 2b/3 Rheumatoid Arthritis Study in Japanese Patients
Apr 05, 2018
Bayer to Showcase Data from Diverse Oncology Pipeline at AACR 2018
Mar 08, 2018
Preventing a Widespread Beauty Fad From Interfering With Medical Tests